Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | amyloid beta (A4) precursor protein | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | Amyloid A4 extracellular domain containing protein | Get druggable targets OG5_131699 | All targets in OG5_131699 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_131699 | All targets in OG5_131699 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_131699 | All targets in OG5_131699 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_131699 | All targets in OG5_131699 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Hypothetical protein | 0.2538 | 0.5747 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.4228 | 0.9825 | 0.9706 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4301 | 1 | 1 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.2538 | 0.5747 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.2538 | 0.5747 | 0.5 |
Schistosoma mansoni | 6-phosphofructokinase | 0.4301 | 1 | 0.5 |
Onchocerca volvulus | 0.4301 | 1 | 0.5 | |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4301 | 1 | 1 |
Brugia malayi | Amyloid A4 extracellular domain containing protein | 0.0369 | 0.0514 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.4228 | 0.9825 | 0.9706 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.4228 | 0.9825 | 0.9706 |
Loa Loa (eye worm) | hypothetical protein | 0.4301 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0291 | 0.0325 | 0.0325 |
Loa Loa (eye worm) | hypothetical protein | 0.4228 | 0.9825 | 0.9825 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4301 | 1 | 1 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.4301 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2466 | 0.5572 | 0.5572 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4228 | 0.9825 | 0.9706 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4301 | 1 | 1 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.2538 | 0.5747 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.2538 | 0.5747 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 7.87 uM | Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay | ChEMBL. | 23799643 |
Inhibition (binding) | = 78.8 % | Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) at 20 uM after 48 hrs by thioflavin T fluorescence assay relative to control | ChEMBL. | 23799643 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.